Nilotinib in Parkinson's Disease
Trial
Phase 2
Completed
July 21, 2020
Tolerance to NeuroEPO in Parkinson Disease
Trial
Phase 1
Completed
July 14, 2020
Mild Cognitive Impairment and Endurance Exercise in Parkinson's Disease
Trial
N/A
Completed
July 13, 2020
Circadian & Homeostatic Synchronization Effect on Waking Mobility in Parkinson's Disease
Trial
N/A
Withdrawn
July 12, 2020
Evaluation of Safety and Tolerability of Fetal Mesencephalic Dopamine Neuronal Precursor Cells for Parkinson's Disease
Trial
Phase 1
Unknown
July 9, 2020
Validation of a Non-Motor Fluctuation Assessment Instrument (NoMoFA) for Parkinson's Disease
Trial
N/A
Completed
July 7, 2020
Cognitive Decline in Non-demented PD
Trial
Phase 4
Completed
July 6, 2020
SMARTfit Training for Parkinson's Disease
Trial
N/A
Terminated
July 6, 2020
Study Investigating Effects of Foliglurax in Patients With Parkinson's Disease (PD) and Healthy Subjects
Trial
Phase 1
Terminated
July 6, 2020
Efficacy and Safety of Rotigotine in the Treatment of Patients With Early Stage of Primary Parkinson's Disease
Trial
Phase 3
Completed
July 1, 2020
A Follow-up of the Influencing Factors of Dyskinesia in Patients With Parkinson's Disease
Trial
N/A
Unknown
June 30, 2020
Inhibition of α-synuclein Cell-cell Transmission by NMDAR Blocker, Memantine
Trial
Phase 3
Unknown
June 30, 2020
Transcranial Direct Current Stimulation for Freezing of Gait
Trial
N/A
Terminated
June 29, 2020
Probiotics-prebiotic Fiber Therapy in Parkinson's Disease Patients With Constipation
Trial
Phase 3
Completed
June 29, 2020
Spinal Cord Stimulation for Gait in Parkinson Disease
Trial
N/A
Unknown
June 22, 2020
Cycling Deep Brain Stimulation on Parkinson's Disease Gait
Trial
N/A
Unknown
June 22, 2020
LRRK2 G2385R Leucocyte and Urine Biomarker Study
Trial
N/A
Unknown
June 17, 2020
Effects of Inspiratory Muscle Training in Patients With Parkinson's Disease
Trial
N/A
Completed
June 17, 2020
An Innovative Disease-net Management Model for Non-communicable Diseases (SIDERA^B)
Trial
N/A
Unknown
June 16, 2020
Safinamide for Levodopa-induced Dyskinesia (PD-LID)
Trial
Phase 3
Withdrawn
June 16, 2020